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InTROduCTIOn
Acute respiratory failure is one of the most frequent reasons 
for hospitalization in intensive care units (ICU) [1]. Dyspnea, 
reflected by hypoxemia and in some cases also by hypercap‑
nia and respiratory acidosis in blood gas analysis, dominates 
in the clinical presentation. A disproportion between alveo‑
lar ventilation and pulmonary blood flow is usually the reason 
for hypoxemia and less often gas diffusion impairment across 
the air‑blood barrier. The main mechanism of hypercapnia 
is alveolar hypoventilation which may be of neurological or‑
igin. The most frequent disorders associated with the periph‑
eral nervous system are myasthenic crisis and acute polyneu‑
ropathies, especially acute inflammatory polyradiculoneurop‑
athy, known as Guillain‑Barré syndrome (GBS). It may lead 
to respiratory muscle paralysis, while in myasthenia muscle 
fatigue increases gradually. As a result of hypoventilation at‑
electasis occurs, and impairment of swallowing and cough re‑
flexe predisposes to pneumonia which aggravates the respira‑
tory failure. In such an event an immediate initiation of respi‑
ratory failure treatment in the ICU and the most rapid caus‑
ative management are crucial [1]. Plasmapheresis (plasma 
exchange) is the management of choice in acute respiratory 
failure associated with GBS and myasthenic crisis [2,3]. The 
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article presents a report on three severe cases of these diseases 
where mechanical ventilation and plasma pheresis treatment 
have been successfully used.
CASE REPORTS
Individuals with Guillain‑Barré syndrome
1. A 48­year­old female patient has been transferred to the 
ICU of our Department from the Department of Neurolo‑
gy at the Jagiellonian University in Krakow. She had a his‑
tory of a two‑day diarrhea, nausea and fatigue which had oc‑
curred 2 weeks earlier. Within 1 week of the symptoms res‑
olution, fasciculation, paresthesiae, fatigue and subsequent‑
ly flaccid paralysis of upper extremities and a marked paresis 
of lower extremities developed. Based on the patient histo‑
ry and typical cerebro‑spinal fluid findings, GBS was diag‑
nosed. With the exacerbation of dyspnea and respiratory mus‑
cle fatigue, the patient was transferred to the ICU where she 
was intubated (despite the absence of significant abnormali‑
ties in the chest X‑ray, arterial blood gases performed on pas‑
sive oxygen therapy with FiO2  0.5:  pO2  65 mmHg,  pCO2 
50 mmHg) and mechanical lung ventilation was under taken. 
Courses of plasmapheresis were introduced. On the 3rd day 
mechanical ventilation was weaned and intubation tube re‑
moved, in 2 weeks the patient was able to walk alone, and af‑
ter one month  she  recovered  completely. A  total  of 10 plas‑
maphereses was performed.
2. A 25­year­old male patient, not treated previously, had 
a mild upper respiratory tract infection three weeks before ad‑
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moniae cultured in the bronchoalveolar lavage fluid – imipen‑
em) were started. Considering a low hemoglobin concentra‑
tion (up to 7.8 g/dl), red cell concentrate was transfused. Cor‑
ticosteroid and ChE inhibitor therapy was continued. Lung 
mechanical ventilation was discontinued after a few days. Af‑
ter  5  plasmaphereses,  the medullar  symptoms  and  diplopia 
resolved and the eye bulb movements were back to normal. 
The extremities muscle strength demonstrated a gradual im‑
provement. The patient was discharged to the Department 
of Neurology.
dISCuSSIOn
A total plasma exchange allows rapid elimination of au‑
toantibodies and proinflammatory cytokines giving hope for 
control over exacerbated autoimmune diseases, however, pos‑
itive results have been obtained only in few diseases, includ‑
ing GBS and myasthenic crisis [2,3]. In both diseases an ob‑
vious advantage of plasmapheresis over high doses of intrave‑
nous immunoglobulins has not been demonstrated, however, 
rapid effects of plasmapheresis support this therapeutic ap‑
proach [4,5]. The efficiency of intravenous corticosteroids has 
not been confirmed either, and oral administration of these 
drugs may even slow down fitness recovery in GBS patients 
[6,7]. Making decisions  regarding plasmapheresis  treatment 
may raise fear of complications associated with the necessi‑
ty of superior vena cava catheterization with a large diameter 
catheter, anticoagulation, removal of coagulation factors dur‑
ing the procedures and the risk of infection.
The plasmapheresis efficiency in the treatment of severe 
forms of GBS, has been demonstrated in several clinical stud‑
ies. Best effects were reported, with the procedure started less 
than 2 weeks before the disease onset and beneficial effects 
even up to 4 weeks [8,9]. The indications are: respiratory fail‑
ure, medullar paralysis and immobility. Only one single‑cen‑
ter, open, randomized trial on the number of plasmaphereses 
in GBS, with intention‑to‑treat analysis was performed, in‑
cluded in the Cochrane systematic review. According to the 
study among patients not requiring mechanical ventilation, 
4 procedures were more efficient than 2, and in mechanical‑
ly ventilated patients increasing the number of plasmaphere‑
ses to 6 did not improve the treatment results compared to 4 
procedures [4]. It seems, however, that the decision on the 
number of plasmaphereses should be individualized depend‑
ing on their clinical condition.
Plasmapheresis introduced in the early stage of GBS, 
an early intubation and mechanical ventilation allow to avoid 
the most severe complications: aspiration pneumonia and se‑
vere respiratory failure [10­12], a good example of which are 
the patients presented in this study. Plasmapheresis was in‑
troduced in the young man already after bronchial aspira‑
tion and pneumonia development. The acute respiratory dis‑
tress syndrome (ARDS) diagnostic criteria were already ful‑
filled. Bilateral interstitial lung lesions and the oxygenation 
mission to the ICU. Several days later, tactile impairment and 
paresthesiae of lower and later of upper extremities occurred. 
He was admitted to the hospital where the cerebrospinal flu‑
id was examined and the test demonstrated protein cell dis‑
sociation  (increased protein  level up to 1.8 g/l, with normal 
cell count). There was characteristic slowing of conduction in 
peripheral nerves shown in electromyography, therefore GBS 
was diagnosed. Despite the intravenous immunoglobin in‑
fusion, a rapid disease progression was observed which after 
several days led to flaccid quadriplegia (only head and neck 
movements were preserved) and to respiratory failure. Aspi‑
ration occurred and subsequently pneumonia developed. The 
patient was intubated, mechanical ventilation was initiated 
and he was transferred to the ICU. On admission, the patient 
condition was critical, because of hemodynamic instability in‑
fusion of sympathomimetic amines was required. The chest 
X‑rays demonstrated diffuse interstitial lung infiltrates. Arte‑
rial blood partial oxygen pressure (PaO2) with passive oxygen 
therapy at 100% oxygen (FiO2 1.0) was 70 mmHg. On neuro‑
logical examination, apart from tetraplegia, there was a com‑
plete absence of deep tendon reflexes and feeling of vibration. 
Because of fever and presence of a resistant to meticilin coag‑
ulase‑negative Staphyllococci in blood culture and Acinetobacter 
baumanni in bronchoalveolar lavage, vancomycin and pipera‑
cillin were administered in combination with tazobactam ac‑
cording to the antibiogram, with the maintenance of the ear‑
lier administered metronidazol. Plasmapheresis was immedi‑
ately started with an exchange of about 3 liters plasma every 
2nd day. A gradual improvement of the respiratory function 
was observed, and on the 6th day the mechanical ventilation 
was weaned. Extremities mobility improved much slower. Af‑
ter 6 weeks of treatment and 11 plasmaphereses the patient 
started to walk with assistance, was able to eat by himself and 
did  not  require  further  oxygen  therapy;  he  was  transferred 
to the Department of Neurology. A full motor efficiency re‑
covery took over 5 months.
A patient with myasthenic crisis
A 49­year­old patient with myasthenia diagnosed 5 years 
ago, with documented specific acetylocholine receptor au‑
toantibodies, on long‑term corticosteroids, after thymectomy 
performed 2 years ago, was admitted to the ICU with myas‑
thenic  crisis.  He  was  previously  hospitalized  in  the Depart‑
ment of Neurology where head drop, ptasis, diplopia, inabil‑
ity to elevate the extremities and paresis intensification with 
effort were reported. Despite treatment with cholinesterase 
inhibitors (ChE), corticosteriods, and high‑dose azathioprine, 
a sudden cardiac arrest took place in the Department of Neu‑
rology as a result of enhanced medullary symptoms and flu‑
id aspiration. On admission to the ICU, the patient was intu‑
bated and mechanically ventilated. In order to clean the bron‑
chi, bronchofiberoscopy was performed. Subsequently plas‑
maphereses, along with antibiotic therapy (empirical at first, 
later guided against Acinetobacter baumanni and Klebsiella pneu-
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treatment. It is often caused by ventilation disorders in the 
course of peripheral nervous system diseases, the most fre‑
quent one being GBS and myasthenic crisis. In both cases, 
therapeutic plasmapheresis (plasma exchange) is the manage‑
ment of choice, and should be started promptly to avoid ad‑
verse events.
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index; the ratio PaO2 and fraction of inspired oxygen (FiO2) 
<200 mmHg (precisely 70 mmHg; PaO2 = 70 mmHg, FiO2 
= 1.0) were observed. The mobility recovery took much lon‑
ger in comparison with the above presented female patient. 
Plasma phereses and mechanical ventilation was introduced 
nearly immediately after respiratory failure symptoms find‑
ings; respiratory muscles exhaustion, which enabled to avoid 
pulmonary (pneumonia, ARDS) and systemic (sepsis) compli‑
cations, which had occurred in the GBS male patient and al‑
lowed quicker recovery.
The patient with myasthenic crisis is an another example, 
confirming that delay in mechanical ventilation introduction 
with already present respiratory muscles exhaustion can lead 
to serious complications. Plasmaphereses are also the manage‑
ment of choice in myasthenic crisis, especially when the ear‑
lier attempts of treating with ChE inhibitors, corticosteroids 
and immunosuppressive drugs were ineffective. The thera‑
peutic plasmapheresis effect is mainly due to the elimination 
of circulating acetylocholine receptor antibodies elevated in 
over 90% of patients with generalized myasthenia. Another 
important aspect of such treatment is the elimination of fac‑
tors able to cause the crisis, such as respiratory tract infection 
[8], as it probably occurred in the presented case.
In the presented patients there were no serious plasmapher‑
eses complications since the principles of aseptic techniques 
during vessel catheter introduction, care and procedure per‑
formance were strictly followed, as well as coagulation sys‑
tem was monitored. Anaemia (without enhanced hemolysis) 
occurred in the male patient with myasthenia, which required 
a single transfusion of red cells. In that patient and in the 
male patient with GBS, however, a respiratory tract infection 
(possibly hospital‑aquired) had developed before start of plas‑
ma exchange.
A careful clinical observation allows finding respiratory 
muscles fatigue symptoms prior to the occurrence of serious 
arterial blood gases abnormalities and plays a key role in deci‑
sion making associated with initiation of plasmapheresis and 
mechanical ventilation both in myasthenic crisis and GBS pa‑
tients. With marked dyspnea and rapid shallow breathing, it 
is not advised to delay plasmaphereses introduction until hy‑
poxemia  and  hypercapnia  occur;  an  early  introduction may 
prevent respiratory failure aggravation which requires me‑
chanical ventilation commencement. Spirometry happens 
to be very helpful in monitoring such patients; usually limit‑
ed to vital capacity assessment attempt, as significant muscle 
weakening makes the forced expiration maneuver impossible.
In GBS and myasthenic crisis associated respiratory fail‑
ure, an invasive mechanical ventilation is conducted (intuba‑
tion necessary) as noninvasive methods usually support venti‑
lation, which means they require the patient’s own respirato‑
ry effort. Moreover, they do not protect the airways from aspi‑
ration and should not be employed in patients incapable of an 
efficient cough.
Acute respiratory failure, including its most severe form, 
the ARDS, has a stormy course and requires an immediate 
